Clinical Outcomes and Molecular Profile of Differentiated Thyroid Cancers With Radioiodine-Avid Distant Metastases

BACKGROUND: Radioiodine (RAI) remains the mainstay of therapy for RAI-avid (RAIA) distant metastatic thyroid carcinoma. We previously demonstrated that RAI-refractory distant metastatic thyroid cancers commonly harbor BRAF mutations. However, the molecular profile of RAIA metastatic thyroid cancer i...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Sabra, M. M., Dominguez, J. M., Grewal, R. K., Larson, S. M., Ghossein, R. A., Tuttle, R. M., Fagin, J. A.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Endocrine Society 2013
विषय:
Hot Topics in Translational Endocrinology
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3644606/
https://ncbi.nlm.nih.gov/pubmed/23533233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2012-3933
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन